Cibus to reduce workforce by 34 positions as part of business refocus

Cibus, Inc. (NASDAQ:CBUS), a small-cap agriculture chemicals company with a market capitalization of $86 million, announced Wednesday that its board of directors has approved a reduction in workforce affecting approximately 34 full-time employees. The company communicated the decision to affected staff the same day.

According to a statement included in a Securities and Exchange Commission filing, the move is part of Cibus’s previously announced plan to streamline its business and prioritize near-term, funded commercial opportunities. The company expects to complete the workforce reduction by December 31, 2025.

Cibus estimates it will incur about $0.5 million in one-time charges related to accrued vacation and severance payments in the third quarter of 2025 as a result of these actions.

The company, which operates in the agriculture chemicals sector, is headquartered in San Diego, California. The announcement was made by Peter Beetham, Interim Chief Executive Officer, in a press release statement.

This report is based on information disclosed in a filing with the Securities and Exchange Commission.

In other recent news, Cibus Inc. has announced a series of significant developments. The company revealed a strategic decision to focus on rice traits, leading to layoffs and anticipated one-time charges of approximately $0.5 million in the third quarter of 2025. In a positive regulatory update, Cibus’ new herbicide tolerance trait for canola, HT2, has been designated as "not regulated" by the USDA, marking a milestone for the company’s expansion potential. The company’s public offering of 15.7 million shares at $1.75 per share is expected to raise around $27.5 million, with the funds allocated to develop weed management traits in rice and for general corporate purposes. However, Canaccord Genuity has adjusted Cibus’ stock price target from $17.50 to $15 following the equity raise, though it maintained a Buy rating. This adjustment reflects the dilution impact due to the increased share count. Cibus’ Chairman of the Board and other strategic investors are participating in the share purchase, underscoring confidence in the company’s future prospects. These developments highlight Cibus’ ongoing efforts to strengthen its financial position and strategic focus.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.